In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosin

被引：0
|
作者：
N Gyémánt
H Engi
Z Schelz
I Szatmári
D Tóth
F Fülöp
J Molnár
P A M de Witte
机构：
[1] Faculty of Medicine,Department of Pharmaceutical Chemistry
[2] Institute of Medical Microbiology and Immunobiology,undefined
[3] University of Szeged,undefined
[4] Faculty of Pharmaceutical Sciences,undefined
[5] Laboratory for Pharmaceutical Biology,undefined
[6] K.U.Leuven,undefined
[7] O&N PB 824,undefined
[8] Faculty of Pharmacy,undefined
[9] University of Szeged,undefined
[10] Zrínyi u.9,undefined
[11] H-6720,undefined
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
P-glycoprotein; resistance; doxorubicin; tumour; Betti-base; tylosin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 185
页数：7
相关论文
共 50 条
  • [1] In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosin
    Gyemant, N.
    Engi, H.
    Schelz, Z.
    Szatmari, I.
    Toth, D.
    Fulop, F.
    Molnar, J.
    de Witte, P. A. M.
    BRITISH JOURNAL OF CANCER, 2010, 103 (02) : 178 - 185
  • [2] Reversal of multidrug resistance in vitro and in vivo by 5-N-formylardeemin, a new ardeemin derivative
    Zheng, Xuelian
    Li, Daoxia
    Zhao, Chen
    Wang, Qiong
    Song, Hao
    Qin, Yong
    Liao, Linchuan
    Zhang, Lin
    Lin, Yong
    Wang, Xia
    APOPTOSIS, 2014, 19 (08) : 1293 - 1300
  • [3] Reversal of multidrug resistance in vitro and in vivo by 5-N-formylardeemin, a new ardeemin derivative
    Xuelian Zheng
    Daoxia Li
    Chen Zhao
    Qiong Wang
    Hao Song
    Yong Qin
    Linchuan Liao
    Lin Zhang
    Yong Lin
    Xia Wang
    Apoptosis, 2014, 19 : 1293 - 1300
  • [4] IN-VITRO AND IN-VIVO REVERSAL OF MULTIDRUG-RESISTANCE BY GF120918, AN ACRIDONECARBOXAMIDE DERIVATIVE
    HYAFIL, F
    VERGELY, C
    DUVIGNAUD, P
    GRANDPERRET, T
    CANCER RESEARCH, 1993, 53 (19) : 4595 - 4602
  • [5] Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative
    Ganguly, Avishek
    Banerjee, Kaushik
    Chakraborty, Paramita
    Das, Satyajit
    Sarkar, Avijit
    Hazra, Abhijit
    Banerjee, Maitrayee
    Maity, Arindam
    Chatterjee, Mitali
    Mondal, Nirup B.
    Choudhuri, Soumitra Kumar
    BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (06) : 387 - 394
  • [6] Reversal of multidrug resistance by amitriptyline in vitro
    Varga, A
    Nugel, H
    Baehr, R
    Marx, U
    Hever, A
    Nacsa, J
    Ocsovszky, I
    Molnar, J
    ANTICANCER RESEARCH, 1996, 16 (01) : 209 - 211
  • [7] <it>In vitro</it> Reversal of Multidrug Resistance in Cancer
    Holcomb-Webb, Kasi
    Gard, Gabrielle
    Vogel, Pia
    Wise, John
    FASEB JOURNAL, 2020, 34
  • [8] In Vitro and In Vivo Inhibition of MRP Gene Expression and Reversal of Multidrug Resistance by siRNA
    Wu, Zhuo
    Li, Xiaobo
    Zeng, Yanyan
    Zhuang, Xiaoming
    Shen, Hong
    Zhu, Haiqing
    Liu, Hongyi
    Xiao, Hong
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 108 (03) : 177 - 184
  • [9] Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole
    Desai, PB
    Duan, J
    Sridhar, R
    Damle, BD
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1997, 19 (04): : 231 - 239
  • [10] Reversal of ABCG2-mediated multidrug resistance by tepotinib in vitro and in vivo
    Wu, Zhuoxun
    Teng, Qiu-Xu
    Yang, Yuqi
    Acharekar, Nikita
    Wang, Jing-Quan
    He, Min
    Yoganathan, Sabesan
    Lin, Jun
    Wang, Jian
    Chen, Zhe-Sheng
    CANCER RESEARCH, 2022, 82 (12)
12345